`_____________________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`_____________________
`
`
`COALITION FOR AFFORDABLE DRUGS II LLC
`Petitioner
`
`v.
`
`
`NPS PHARMACEUTICALS, INC.
`Patent Owner
`
`_____________________
`
`Case No. To Be Assigned
`Patent No. 7,056,886
`_____________________
`
`APPENDIX OF EXHIBITS
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`EXHIBIT
`1001
`
`DESCRIPTION
`Declaration of Dr. Anthony Palmieri III, Ph.D., R.Ph.
`
`FILED
`
`
`1002
`
`1003
`
`1004
`
`1005
`
`1006
`
`1007
`
`1008
`
`1009
`
`1010
`
`1011
`
`1012
`
`1013
`
`1014
`
`1015
`
`1016
`
`1017
`
`1018
`
`1019
`
`1020
`
`CV of Dr. Palmieri
`
`U.S. Patent No. 7,056,886 to Isaacs
`
`U.S. Patent Application Ser. No. 09/750,022
`
`U.S. Patent No.5,496,801 to Holthuis et al.
`
`U.S. Patent No.6,120,761 to Yamazaki et al.
`
`March 8, 2002 Non Final Office Action
`
`June 10, 2002 Amendment and Reply
`
`February 5, 2003 Non Final Office Action
`
`July 9, 2003 Amendment and Reply
`
`September 16, 2003 Non Final Office Action
`
`March 16, 2004 Amendment and Reply
`
`June 8, 2004 Final Office Action
`
`September 7, 2004 Amendment and Reply
`
`October 4, 2004 Non Final Office Action
`
`January 4, 2005 Amendment and Reply
`
`April 4, 2005 Notice of Allowance and Fee(s) Due
`
`Kieffer & Habener, The Glucagon-Like Peptides,
`Endocrine Reviews 20(6): 876-913 (1999)
`
`Lomize et al., Thermodynamic Model of Secondary
`Structure for α-Helical Peptides and Proteins,
`Bioploymers 42:239 (1997)
`
`Dacambra et al., Structural Determinants for Activity of
`Glucagon-like Peptide-2. Biochemistry 39:8888-8894
`
`
`
`2
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`1021
`
`1022
`
`1023
`
`1024
`
`1025
`
`1026
`
`1027
`
`1028
`
`1029
`
`1030
`
`(July 2000)
`
`Drucker et al., Regulation of the biological activity of
`glucagon-like peptide 2 in vivo by dipeptidyl peptidase
`IV, Nat. Biotechnol. 15(7):673-7. (July 1997)
`
`Munroe et al.,Prototypic G-protein coupled receptor for
`the intestinotrophic factor glucagon –like peptide 2,
`Proc. Nat’l Acad. Sci. 96:1569 (1999)
`
`Drucker et al., Human [Gly2]GLP-2 reduces the
`severity of colonic injury in a murine model of
`experimental colitis, Am J. Physiology 276:G79 (1999)
`
`Cleland et al., Formulation and Delivery of Proteins and
`Peptides, American Chemical Society,Washington D.C.,
`Chapter 1 (1994)
`
`WO 99/043361 to Knudsen
`
`U.S. Patent No. 4,985,244 to Makino
`
`U.S. Patent No. 5,652,216 to Kornfelt et al.
`
`PCT Publication WO98/52600
`
`U.S. Patent No. 5,789,379 to Drucker et al.
`
`Osterberg et al., Physical state of L-histidine after
`freeze-drying and long-term storage, EP. J. of Pharm.
`Sci. 1999 Aug., 8:301-308.
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`3
`
`